Louwe Mieke C, Olsen Maria B, Kaasbøll Ole J, Yang Kuan, Fosshaug Linn E, Alfsnes Katrine, Øgaard Jonas D S, Rashidi Azita, Skulberg Vidar M, Yang Mingyi, de Miranda Fonseca Davi, Sharma Animesh, Aronsen Jan Magnus, Schrumpf Elisabeth, Ahmed Muhammad Shakil, Dahl Christen Peder, Nyman Tuula A, Ueland Thor, Melum Espen, Halvorsen Bente E, Bjørås Magnar, Attramadal Håvard, Sjaastad Ivar, Aukrust Pål, Yndestad Arne
Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
Institute for Surgical Research, Oslo University Hospital, Oslo, Norway.
JACC Basic Transl Sci. 2020 Dec 9;5(12):1210-1224. doi: 10.1016/j.jacbts.2020.09.013. eCollection 2020 Dec.
An inflammatory response is required for tissue healing after a myocardial infarction (MI), but the process must be balanced to prevent maladaptive remodeling. This study shows that improved survival and cardiac function following MI, in mice deficient for the NLRP3 inflammasome, can be recapitulated in wild-type mice receiving bone marrow from mice. This suggests that NLRP3 activation in hematopoietic cells infiltrating in the myocardium increases mortality and late ventricular remodeling. Our data should encourage performing clinical trials directly targeting NLRP3 inflammasome and their inflammatory cytokines (interleukin-1β and -18) in MI patients.
心肌梗死(MI)后组织愈合需要炎症反应,但该过程必须保持平衡以防止适应性不良的重塑。本研究表明,在缺乏NLRP3炎性小体的小鼠中,MI后生存率和心脏功能的改善可以在接受来自小鼠骨髓的野生型小鼠中重现。这表明浸润心肌的造血细胞中NLRP3的激活会增加死亡率和晚期心室重塑。我们的数据应鼓励针对MI患者直接靶向NLRP3炎性小体及其炎性细胞因子(白细胞介素-1β和-18)开展临床试验。